TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive DeVita Says He Did Not Agree To Include “Chop-Like” Elements In CCOP RFA But That He Would Consider It March 19, 1982
TCL Archive Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility February 1, 1980
TCL Archive Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System June 25, 2010
